Javascript must be enabled to continue!
Clinical and Immunological Characteristics for BK Polyomavirus- associated Nephropathy after Kidney Transplantation
View through CrossRef
Abstract
Background
BK polyomavirus (BKPyV)-associated nephropathy (BKPyVAN) could cause allograft dysfunction among kidney transplant (KT) recipients. Intact BKPyV-specific immunity is correlated with viral containment, therefore clinical and immunological characteristics related to BKVAN after KT needs to be explored.
Methods
We prospectively investigated an association between clinical baseline characteristics, BK polyomavirus (BKPyV)-specific immunity, and BKPyV-associated nephropathy (BKPyVAN) in KT recipients. BKPyV-specific immunity, measured with intracellular cytokine assays, is reported as the percentage of IFN-γ-producing CD4+ T, CD8+ T, natural killer (NK), and NKT cells after large-T antigen and viral capsid protein 1 (VP1) stimulation.
Results
Among 100 KT patients, BKPyVAN occurred in 18% within one-year post-KT. There were 70 patients (70%) who received an induction immunosuppressive therapy. Diabetic nephropathy was significantly associated with BKPyVAN. Among 40 patients who were eligible for the immunological study. In a multivariate analysis, pre-KT %VP1-specific NK cells were independently associated with BKPyVAN (HR, 1.209; 95%CI, 1.055–1.386; P = 0.006). In those with BKPyVAN, the mean %NK (coefficient, 1.202; 95%CI, 0.033–2.371; P = 0.04), %VP1-specific NK (coefficient, 2.602; 95%CI, 1.083–4.121; P = 0.001), and %NKT (coefficient, 0.199; 95%CI, 0.051–0.348; P = 0.008) cells at 1-month post-KT were significantly higher than those pre-KT. Thus, increasing NK, VP1-specific NK, and NKT cell proportions were observed among KT recipients who developed BKPyVAN within the first year.
Conclusion
KT recipients with underlying diabetes and the presence of BKPyV-specific NK- and NKT-cell immunity could be at risk of BKPyVAN after KT. BKPyV-specific innate immune monitoring could potentially stratify those at risk of BKPyVAN among KT recipients. (Thai Clinical Trials Registry, TCTR20190404004)
Title: Clinical and Immunological Characteristics for BK Polyomavirus- associated Nephropathy after Kidney Transplantation
Description:
Abstract
Background
BK polyomavirus (BKPyV)-associated nephropathy (BKPyVAN) could cause allograft dysfunction among kidney transplant (KT) recipients.
Intact BKPyV-specific immunity is correlated with viral containment, therefore clinical and immunological characteristics related to BKVAN after KT needs to be explored.
Methods
We prospectively investigated an association between clinical baseline characteristics, BK polyomavirus (BKPyV)-specific immunity, and BKPyV-associated nephropathy (BKPyVAN) in KT recipients.
BKPyV-specific immunity, measured with intracellular cytokine assays, is reported as the percentage of IFN-γ-producing CD4+ T, CD8+ T, natural killer (NK), and NKT cells after large-T antigen and viral capsid protein 1 (VP1) stimulation.
Results
Among 100 KT patients, BKPyVAN occurred in 18% within one-year post-KT.
There were 70 patients (70%) who received an induction immunosuppressive therapy.
Diabetic nephropathy was significantly associated with BKPyVAN.
Among 40 patients who were eligible for the immunological study.
In a multivariate analysis, pre-KT %VP1-specific NK cells were independently associated with BKPyVAN (HR, 1.
209; 95%CI, 1.
055–1.
386; P = 0.
006).
In those with BKPyVAN, the mean %NK (coefficient, 1.
202; 95%CI, 0.
033–2.
371; P = 0.
04), %VP1-specific NK (coefficient, 2.
602; 95%CI, 1.
083–4.
121; P = 0.
001), and %NKT (coefficient, 0.
199; 95%CI, 0.
051–0.
348; P = 0.
008) cells at 1-month post-KT were significantly higher than those pre-KT.
Thus, increasing NK, VP1-specific NK, and NKT cell proportions were observed among KT recipients who developed BKPyVAN within the first year.
Conclusion
KT recipients with underlying diabetes and the presence of BKPyV-specific NK- and NKT-cell immunity could be at risk of BKPyVAN after KT.
BKPyV-specific innate immune monitoring could potentially stratify those at risk of BKPyVAN among KT recipients.
(Thai Clinical Trials Registry, TCTR20190404004).
Related Results
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Today, the incidence of type 2 diabetes mellitus is increasing rapidly on global. This disease is shown with many complications that significantly affect public health. One of them...
Kidney Tissue Reconstruction by Fetal Kidney Cell Transplantation: Effect of Gestation Stage of Fetal Kidney Cells
Kidney Tissue Reconstruction by Fetal Kidney Cell Transplantation: Effect of Gestation Stage of Fetal Kidney Cells
Abstract
Dialysis and kidney transplantation, current therapies for kidney failure, have limitations such as severe complications, donor shortage, and immune-related...
Novel Human Polyomaviruses Discovered From 2007 to the Present: An Update of Current Knowledge
Novel Human Polyomaviruses Discovered From 2007 to the Present: An Update of Current Knowledge
ABSTRACT
Human polyomaviruses (HPyVs) are a diverse group of viruses that typically establish asymptomatic persistent infections in healthy individuals. However, ...
Risk factors for new‐onset diabetes mellitus after kidney transplantation: A systematic review and meta‐analysis
Risk factors for new‐onset diabetes mellitus after kidney transplantation: A systematic review and meta‐analysis
AbstractAims/IntroductionTo systematically review the risk factors for new‐onset diabetes mellitus after kidney transplantation, and to provide a theoretical basis for the preventi...
Non-Inferiority of Dual Kidney Transplantation: A Retrospective Matched Study
Non-Inferiority of Dual Kidney Transplantation: A Retrospective Matched Study
Background/Objectives: Dual kidney transplantation is a potential technique to reduce the number of discarded kidneys from expanded-criteria donors. Due to allegedly poor outcomes,...
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
The primary cause of End-stage Renal Disease (ESRD) and a possible chronic microvascular
consequence of diabetes mellitus is Diabetic Nephropathy (DN). The early stages of diabetic...
#6774 CAUSAL ASSOCIATION OF COVID-19 AND KIDNEY FUNCTION: A MENDELIAN RANDOMIZATION ANALYSIS
#6774 CAUSAL ASSOCIATION OF COVID-19 AND KIDNEY FUNCTION: A MENDELIAN RANDOMIZATION ANALYSIS
Abstract
Background and Aims
Previous observational studies suggest that there are potential relationships between COVID-19 and ...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...

